• 340B Refunds to Manufacturers? An Interesting New Twist

    As entities contact manufacturers with a need to repay the manufacturers, manufacturers are not sure how to best handle these requests. Read this post to learn some thoughts on this situation, as shared by a consulting firm to the industry. http://cis-partners.com/cis-compliance-blog/340b-refunds-to-manufacturers-an-interesting-new-twist/

  • HRSA published final rule on Orphan Drugs

    On July 23, 2013, the Health Resources and Services Administration (HRSA) published a final rule to clarify how section 340B(e) of the Public Health Service Act (PHSA) will be implemented (“Exclusion of Orphan Drugs for Certain Covered Entities under 340B Program”, (78 Fed. Reg. 44016 (July 23, 2013)). The final rule only applies to Critical… Read more »

  • Shift to Outpatient care, Payer Pressure Hits Hospitals.

    Beth Kutscher , Melanie Evans Posted: August 10, 2013 – 12:01 am ET Three years ago, Henry Ford Health System began to overhaul how its doctors and nurses care for patients outside the Detroit-based system’s six hospitals. Now it must face the economic strains of its own success, as fewer patients turn up to fill hospital beds.Since January, the… Read more »

  • Health Care Law Raises Pressure on Public Unions

    By KATE TAYLOR Published: August 4, 2013  Cities and towns across the country are pushing municipal unions to accept cheaper health benefits in anticipation of a component of the Affordable Care Act that will tax expensive plans starting in 2018. The so-called Cadillac tax was inserted into the Affordable Care Act at the advice of economists who argued… Read more »

  • Federal Register -Orphan Drug Release

    HRSA has released its final ruling in the Federal Registry regarding  the use of Orphan Drugs in the 340B discount drug program. The link below can be used to read the federal register notice containing the final ruling on the use of the Orphan drug list within the 340B program.  Use of these drugs is… Read more »

  • Hospitals look to reform 340b drug discount program

     Jaimy Lee Posted: July 9, 2013 – 6:45 pm ET- Modern Health Safety net hospitals issued recommendations Tuesday for reforming the federal 340b drug discount program, which was designed to help clinics and hospitals serving the poor and uninsured but has become controversial because of alleged misuse by some hospitals.The recommendations included increased transparency of 340b prices and… Read more »

  • Lawmakers call for delay of DMEPOS program

    By Rachel Landen Posted: June 6, 2013 – 6:45 pm ET Lawmakers on both sides of the aisle have asked CMS Administrator Marilyn Tavenner to delay the second-round implementation of Medicare’s Durable Medical Equipment Prosthetics, Orthotics and Supplies (DMEPOS) competitive-bidding program, scheduled to take effect July 1. Reps. Glenn Thompson (R-Pa.) and Bruce Braley (D-Iowa) have circulated a… Read more »

  • FDA panel favors easing safety limits on Avandia

    By Associated Press Posted: June 6, 2013 – 5:00 pm ET Federal health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as much as previously thought. A majority on a Food and Drug… Read more »

  • Health reform plans, pricing revealed in California

    By Associated Press Posted: May 24, 2013 – 8:00 am ET Californians are finally getting to see what “Obamacare” means for them. President Barack Obama’s healthcare overhaul made a big leap Thursday when California’s health insurance exchange announced the plans and the prices that will be offered to those buying individual coverage. Some of the… Read more »